The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation. When worn firmly on the calf, the Venowave produces a wave form motion forcing blood from the feet and legs back to the heart. This increase in blood flow draws oxygen to wound and ulcer sites, prevents blood pooling and clotting, and alleviates symptoms of Post Thrombotic Syndrome and other Chronic Venous Insufficiencies.

The product is unique because it is lightweight (250 g or less than ½ a pound), discreet (can be worn under pants or skirts easily), and allows patients to remain completely mobile. There are no wires or tubes.

The patented Venowave technology, developed by engineer John Saringer and co-developed by world-renowned clinical researcher and hematologist, Dr. Jack Hirsch,  ensures the wearer will never have to worry about immobility ever again. The comfort and ease of use in this new technology results in a higher patient compliance and better overall results.

Core Venowave Features From Research & Development Efforts:

Mobile:  Weighing less than 0.5 pounds each, the Venowave fits snuggly to the back of each calf. No cords, no compression tanks – just two “AA” batteries needed for operation. This revolutionary technology permits you to participate in normal lifestyle activities that were once impossible with bulky, noisy, and immobile devices.

Simple-to-use: From the hospital to the home, Venowave technology is easy and simple treatment device to adopt for DVT and PE patients of all ages and health conditions. The device’s large neoprene straps are adjustable and breathable – providing comfort for legs and calves of all sizes. Regardless of your leg position, the product automatically adjusts its massage-like therapy to keep your blood circulation flowing normal. 

Life-saving: The life-threatening effects of DVT, Chronic Venous Insufficiency (CVI), and Post Thrombotic Syndrome (PTS) are greatly reduced with the use of our product. Its venous-return assisting capabilities are designed to: (i) Treat primary thrombosis, (ii) Enhance circulation NS (iii) Decrease post-operative limb pain and swelling.  (Clinical research conducted on patients suffering from Post Thrombotic Syndrome (PTS) concluded that the Venowave technology increased venous blood flow by 64% after 2 minutes of use and an 88% increased blood flow after 50 minutes of use. Researchers further concluded that compared with standard PTS therapies, approximately one-third of severe PTS patients reported clinical improvement.)

Practical and preventive: Due to its simplicity and mobility, patients can wear the Venowave product immediately following discharge from their surgical facility and continue the same level of medical treatment comfortably at  home or on the go. The practicality and convenience of the Venowave device will promote greater compliance rates amongst patients and, ultimately healthier, happier lives.